AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
My Activity
EN
Login
EN
Surge Analysis
/
Cyclacel Pharmaceuticals, Inc.
/
2026-06-05
▲ SURGE
Cyclacel Pharmaceuticals, Inc.
+41.5%
BGMS
NASDAQ
Healthcare
2026-06-05
1.5
Close
1.06
Prev Close
+41.51%
Change
3.8x
Vol Ratio
Why It Surged
No related news available.
Related News
BeOne Medicines Advances BG-A3004 Into First-in-Human Skin Disease Trial: What Investors Should Watch
Tipranks
2026-03-19
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Weeklyvoice
2026-04-03
Sangamo Therapeutics Reports No Unregistered Equity Sales or Share Repurchases for the Period
Tipranks
2026-05-16
BioXcel says at-home agitation drug could target 86M yearly episodes
Stocktitan
2026-03-27
Watch Axsome’s June investor fireside chats at five industry conferences
Stocktitan
2026-05-27
Technical Analysis
Signals
BB Upper Break
Overbought
MACD Bullish
Above SMA20
Key Indicators
79.00
RSI (14)
1.02
SMA 20
0.77
Bollinger Lower
1.28
Bollinger Upper
1.02
Bollinger Mid
0.05
MACD
0.02
MACD Signal
0.04
MACD Hist
View Company
Back to Surge Stocks
Home
Chat
Portfolio
Activity
Menu
Cyclacel Pharmaceuticals, Inc. Surged +41.5% on 2026-06-05 — Analysis | Alpha Lenz